Imidazoline derivatives are pharmacolo gically classified into several groups: a adrenoceptor agonists, e.g., clonidine and naphazoline; a-adrenoceptor antagonists, e.g., phentolamine and tolazoline; and anti histaminics, e.g., antazoline. Extensive anti hypertensive screening of various 2 imidazoline derivatives by our laboratories has resulted in the selection of 2-(5-chloro-2 phenoxyanilino)-2-imidazoline (FR35447) for further study (Fig. 1 ). As described in detail elsewhere (1), FR35447 has a pro tective effect on arachidonate-induced cerebral infarction in rats, whereas prazosin or hydralazine showed no significant improve ment. The protective effect of FR35447 is presumed to be due to its free radical scaveng ing activity, synergistic effect on PG12 induced inhibition of platelet aggregation, and/or increase in red cell deformability. We describe here the pharmacological properties of FR35447 as an antihypertensive agent. Single administration: Blood pressure was measured with a pressure transducer through a polyethylene cannula inserted into the femoral artery and recorded on a polygraph. Heart rate was counted from the recording chart of blood pressure. The test drug or the vehicle (0.5% methyl cellulose) was given by a stomach tube to rats fasted for 18 hr before the experiment.
Repeated administration: A polyethylene cannula was implanted in the lower part of the abdominal aorta via the femoral artery. Three to four days after implantation, the experiments were started. The drug or the vehicle (0.5% methyl cellulose) was given orally by stomach tube to animals fasted for 3 hr before dosing once a day for 5 con secutive days. Blood pressure was measured on the 1 st, 3rd and 5th days.
The experiments were conducted using groups of 5 animals. (1 mg/kg, i.v.) was also given to counteract the ,3-adrenoceptor mediating effect. The dose-response curve to each vasopressor agent was obtained before and 5 min after i.v. injection of each test drug. The experiments were conducted using groups of 5 rats. Blocking activity on pre and postsynaptic a adrenoceptors in the isolated vas deferens of rats
The vas deferens was removed from Sprague Dawley rats weighing 250-320 g. A 2 cm section, including mainly the central portion of the vas deferens, was excised and suspended in a 25 ml organ bath containing Krebs solution. When the twitch response to field stimulation was studied, the concen tration of magnesium sulfate in Krebs solution was reduced by one half. The bath fluid was aerated with 95% 02 and 5% CO2. The temperature of the bath fluid was maintained at 37 °C to study twitch response and reduced to 30°C to decrease spontaneous con tractions when phenylephrine-induced con tractions were studied.
Contraction of the isolated preparations
was measured with an isometric strain gauge and under a resting tension of 0.3-0.5 g.
Effect on presynaptic a-adrenoceptors: A platinum-electrode was placed at each end of the vas deferens. Continuous field stimu lation was carried out at 0.2 Hz, 3 msec and 50-55 V. Clonidine, an a2 agonist, inhibits the twitch response of the field-stimulated vas deferens by acting on the presynaptic a adrenoceptors.
Blocking activity of a antagonists was assessed by the antagonism of the a2-agonist, clonidine. Control dose response curves and those in the presence of antagonist were obtained in separate pre parations since full recovery from maximally effective concentrations of clonidine could not be obtained by washout. Each antagonist was added to the bath and allowed to be in contact with the vas deferens for 1 5 min prior to initiation of cumulative addition of clonidine.
Effect on postsynaptic a-adrenoceptors: Blocking activity on the postsynaptic a adrenoceptors was assessed by the antago nism of phenylephrine-induced contractions. Dose-response curves to phenylephrine-HCI were obtained before and after addition of each antagonist.
The experiments were conducted using preparations from 3-5 different animals. Effect on plasma renin activity in rats Male Wistar rats weighing 232-267 g were fasted for 18 hr. Under ether anesthesia, a polyethylene cannula was inserted in the femoral artery for collection of blood. One half ml of blood was withdrawn from the cannula before and 30 min after p.o. adminis tration of the test drugs. The blood was mixed with 7.5 id of 6% EDTA•Na2 and centrifuged at 3000 r.p.m. for 10 min (4°C). Plasma renin activity, measured by a radio immunoassay kit (CIS), was expressed as the amount of angiotensin I generated by incubating 1 ml of plasma for 1 hr. The experiments were conducted in groups of 5 animals. (Table  1) , which mean the doses required for 30% decrease in blood pressure, the hypotensive effect of FR35447 was comparable to that of prazosin and was more potent than that of hydralazine. However, as shown in Fig. 2 , the duration was shorter. Clonidine showed a slight but long-lasting hypotension in low doses. High doses of the drug induced a dual effect: a short-lasting hypertension followed by a long-lasting hypotension. FR35447 increased heart rate as did prazosin, but the effect was not as prominent Table 1 . Effect (ED3oo') of a single oral dose of FR35447 and other antihypertensive agents on mean arterial blood pressure in conscious rats (n=5) Fig. 2 . Effect of oral administration of FR35447 and other antihypertensive agents on mean arterial blood pressure and heart rate in conscious spontaneously hypertensive rats. Symbols represent the mean change±S.E. of 5 rats. 0 Vehicle, * 0.01 mg/kg, V 0.1 mg/kg, • 0.32 mg/kg, A 1.0 mg/kg, • 3.2 mg/kg, V 10 mg/kg.
as that of hydralazine. Clonidine decreased the parameter in a dose-dependent manner. Repeated oral administration of FR35447 or prazosin, 1 mg/kg each, once a day for 5 consecutive days, to renal and spontaneously hypertensive rats caused hypotension and no tachyphylaxis appeared. In contrast, marked tachyphylaxis to hydralazine and phentol amine occurred (Table 2) . Fig. 3 . Effect of intravenous injection of FR35447 and other antihypertensive agents on mean arterial blood pressure in anesthetized cats. Symbols represent the mean % change +S.E. of 3-5 animals.
• Vehicle, 0 1 mg/kg FR35447, A 0.1 mg/kg prazosin, El 10 mg/kg hydralazine, * 0.1 mg/kg clonidine.
Effect on blood pressure in anesthetized cats To determine if FR35447 causes hypo tension through the CNS, the effect of intravenous and intracerebroventricular in jection was compared.
FR35447 caused a dose-dependent hypotension in i.v. doses of 0.01-1.0 mg/kg (data not shown). The hypotensive effect elicited by 1 mg/kg of the drug was almost the same as that by 0.1 mg/ kg prazosin or 10 mg/kg hydralazine. Clonidine at an i.v. dose of 0.1 mg/kg induced transient hypertension followed by long-lasting hypotension (Fig. 3) . Following intracerebroventricular injection clonidine caused marked hypotension in doses of 1-100 itg/animal, whereas FR 35447, prazosin and hydralazine had only a slight hypotensive effect (Table 3) . Effect on cardiac output and blood pressure in anesthetized dogs (Fig. 4) Whereas FR35447 in i.v. doses of 0.1-1 mg/kg induced a dose-dependent hypo tension, its effect on cardiac output was transient and dose-independent.
Almost the same effect was obtained after injection of prazosin. In contrast to these two agents, hydralazine in doses of 0.1-10 mg/kg induced a long-lasting increase in cardiac output. Effect on pressor response to vasoactive agents in pithed rats
The diastolic pressure of pithed rats prior To test blocking activity on postsynaptic a, and a2-adrenoceptors, the effect on the pressor response to phenylephrine, nor adrenaline and B-HT 933 was compared in pithed rats (Fig. 5 and Table 4 ). Prazosin (0.1 mg/kg, i.v.), a specific a,-antagonist, inhibited phenylephrine induced hyper tension markedly, but showed no effect on pressor response to B-HT 933. In contrast to prazosin, yohimbine (1 mg/kg, i.v.), an a2 antagonist, selectively antagonized the pressor response to B-HT 933. After i.v. treatment with FR35447 (1 mg/kg), the dose response curves to these agonists shifted in parallel to the right. This antagonistic effect of FR35447 was somewhat more marked towards a2-adrenoceptors. Blocking activity on pre and postsynaptic a-adrenoceptors in the isolated rat vas deferens (Table 5) FR35447 displaced the dose-response curves of clonidine and phenylephrine to the right, and the pA2 values were 7.88 and 7.41, respectively.
According to the pA2 values, the potency on presynaptic receptors (a2) was about 3 times greater than that on postsynaptic receptors (a, Effect on plasma renin activity in rats As shown in Table 6 , plasma renin activity significantly increased from 14.4 to 171.7 ng Ang I/ml/hr 30 min after oral administration of FR35447 (1 mg/kg). This elevation was completely suppressed by simultaneous administration of propranolol (10 mg/kg). Prazosin (1 mg/kg, p.o.) or hydralazine (10 mg/kg, p.o.) also caused a significant increase in plasma renin activity. Effect on urinary excretion of electrolytes and urine volume in rats As shown in Fig. 6 , FR35447 had no effect in p.o. doses up to 1 mg/kg. Urine volume and urinary excretion of electrolytes decreased to one half of the control in doses of 3.2-10 mg/kg. Prazosin showed the same tendency. Hydralazine in doses of 1-10 mg/kg decreased all parameters in a dose-dependent manner. Effect on serum glucose level in rats FR35447 up to 10 mg/kg had no effect on serum glucose level in rats. Prazosin caused a dose-dependent increase in p.o. doses of 1.0-10 mg/kg with a maximum increase at 10 mg/kg (Fig. 7) . 
Discussion
FR35447 induced dose-dependent hypo tension in several kinds of conscious rats. According to the ED30o,o value, which means the dose required for a 30% decrease in blood pressure, the effect of FR35447 was com parable to that of prazosin, a specific al adrenoceptor antagonist (2, 3), and was greater than that of hydralazine, a direct acting vasodilator (4), whereas the duration of FR35447 was shorter than that of hydralazine or prazosin. With FR35447 or prazosin, a moderate tachycardia appeared concomitantly with a fall in blood pressure, but the effect was not as prominent as that of hydralazine.
Administration of FR35447, as well as prazosin, to conscious renal and spon taneously hypertensive rats for 5 consecutive days induced no significant reduction in the intensity of the hypotensive effect. In con trast, marked tachyphylaxis to hydralazine and phentolamine appeared. The exact mechanism of tolerance to hydralazine is uncertain, but an increase in cardiac output and/or retention of Na and water seem to play an important role (5, 6). The increase in cardiac output as well as the increase in heart rate is thought to occur as a consequence of reflex sympathetic activation (4, 5). FR35447 or prazosin induced only a transient increase in cardiac output, whereas hydralazine induced a long-lasting increase in cardiac output in anesthetized dogs. This difference may contribute to no development of tolerance to FR35447 or prazosin. Hydralazine -induced retention of Na and water is thought to be a consequence of increased sodium reabsorption in the proximal tubules (7) which, at least in part, results from increased plasma renin activity (5). However, since FR35447 and prazosin as well as hydralazine increased plasma renin activity in rats, plasma renin activity was ruled out as a mechanism for no development of tolerance to FR35447.
Hydralazine significantly decreased urine volume and urinary sodium excretion at a p.o. dose of 1 mg/kg, but this dose showed no significant effect on the blood pressure of normotensive rats. Hydralazine in p.o. doses of 3.2 mg/kg or higher induced a significant hypotension.
Although FR35447 also induced some decrease in urine volume and urinary sodium excretion, the threshold dose for these effects (3.2 mg/kg, p.o.) was ten times higher than the dose needed to induce the hypotensive effect (0.32 mg/kg, p.o.) in normotensive rats. These differences between hydralazine and FR35447 may influence the development of tolerance in blood pressure response.
FR35447 is chemically classified as a 2 imidazoline derivative as is clonidine, which is an a-agonist, and causes hypotension through the CNS (8-10). However, since FR35447 showed no marked hypotensive effect when injected into the cerebral ventricle of anesthetized cats, the drug induced hypotension does not appear to be via the CNS. Clonidine given peripherally showed marked hypertension, which was followed by long-lasting hypotension in conscious rats and anesthetized cats, whereas FR35447 caused no increase in blood pressure.
Since clonidine-induced hyper tension is thought to be produced by stimu lation of peripheral a-adrenoceptors (8-10), it appears that FR35447 does not have an agonistic effect on a-adrenoceptors.
Since FR35447 inhibited the pressor response to noradrenaline but not that to angiotensin II or vasopressin in pithed rats, FR35447-induced hypotension seems to be derived from its blocking activity on the a adrenoceptors.
The specific ai -antagonist prazosin selectively inhibited phenylephrine-induced contraction of the isolated rat vas deferens. In contrast, the selective a2-antagonist yohimbine (11) had a greater affinity for the presynaptic a2-adrenoceptors, i.e., inhibition of the clonidine-induced inhibition of twitch. Phentolamine had fairly equal affinities for both a-adrenoceptors.
These results are consistent with the data reported by Shoji (12), although he used noradrenaline as a postsynaptic a-adrenoceptor agonist. The blocking activity of FR35447 on presynaptic a2-adrenoceptors was somewhat greater than that on postsynaptic a, -adrenoceptors. However, the selectivity was far less than that of yohimbine.
Recent reports suggest two populations of postsynaptic a-adrenoceptors: one is sus ceptible to prazosin and the other resistant to prazosin but susceptible to yohimbine. These can be classified as ai and a2-adrenoceptors, respectively (13-15). Langer et al. (16) have proposed that the postsynaptic vascular a, adrenoceptors are located predominantly intrasynaptically, whereas the postsynaptic a2-adrenoceptors are mainly extrasynaptic and readi!y accessible by circulating agonists. After i.v. treatment with FR35447 the dose vasopressor response curves to all a agonists shifted in parallel to the right. The antagonistic effect of FR35447 was some what more marked towards B-HT 933, an a2-agonist (17), but the selectivity was far less than that of yohimbine as was the result obtained in the isolated rat vas deferens.
Oral administration of prazosin was followed by a rise in plasma glucose in rats. This result is consistent with the data in patients with hypertension reported by Barbieri et al. (18) . In contrast to prazosin, FR35447 showed no significant effect on blood glucose in rats.
In conclusion, FR35447 has a potent antihypertensive effect which seems to be derived from its blocking activity on the a adrenoceptors.
Repeated administration of the drug induced no tachyphylaxis. Different from prazosin, FR35447 showed no sig nificant effect on rat blood glucose.
